MedTrace Logo

Special Drug Use Investigation for LAMICTAL® (Long Term)

NCT01863602 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 850

Last updated 2016-11-09

No results posted yet for this study

Summary

The objectives of this post-marketing surveillance (PMS) are to grasp the actual use of lamotrigine tablets to collect safety information in the long-term use according to seizure type and concomitant antiepileptic drug (AED), and to confirm its efficacy.

Conditions

Interventions

DRUG

Lamotrigine tablets

Administered for long-term according to the prescribing information in the locally approved label by the authorities.

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2016-07-31
Completion
2016-07-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01863602 on ClinicalTrials.gov